Statistics
Publications
248
Citations
38.5K
H-Index
92
Active since
1986
Ian E. Krop is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and pharmacology.
Publications per year
1986–2025
248
248
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
Sunil Verma, David Miles, Luca Gianni et al. · New England Journal of Medicine · 2012 · 3.8K citations · Full text
Medicine, Oncology, Pharmacology +14
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
Fátima Cardoso, A. Costa, Elżbieta Senkus et al. · Annals of Oncology · 2016 · 2.1K citations · Full text
Medicine, Oncology, Breast Oncology +11
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer
Shanu Modi, Cristina Saura, Toshinari Yamashita et al. · New England Journal of Medicine · 2019 · 2K citations · Full text
Medicine, Oncology, Pharmacology +17
CDK4/6 inhibition triggers anti-tumour immunity
Shom Goel, Molly J. DeCristo, April C. Watt et al. · Nature · 2017 · 1.5K citations · Full text
Medicine, Cancer Biology, Oncology +12
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
Rashmi K. Murthy, Sherene Loi, Alicia Okines et al. · New England Journal of Medicine · 2019 · 1.3K citations · Full text
Medicine, Oncology, Pharmacology +12
1–5 of 248